Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock
Jaime Hernández-Montfort(Baylor Scott & White Health), Navin K. Kapur(Tufts Medical Center), Maya Guglin(Indiana University Health), Claudius Mahr(Medical City Dallas Hospital), A.R. Garan(Beth Israel Deaconess Medical Center), Shashank S. Sinha(Inova Fairfax Hospital), Michael T. Yin(Aaron Diamond AIDS Research Center), Rachna Kataria(Massachusetts General Hospital), Katherine Thayer(Tufts Medical Center), Fatou Dieng(Tufts Medical Center), Daniel Burkhoff(Columbia University Irving Medical Center), Song Li(University of Pittsburgh), Wissam Khalife(The University of Texas Medical Branch at Galveston), Andrew Schwartzman(Maine Medical Center), Mohit Pahuja, Manreet Kanwar(University of Chicago), Esther Vorovich(Northwestern University), Paulina Baca(Tufts Medical Center), Jacob Abraham(Providence St. Vincent Medical Center), Detlef Wencker(Baylor Scott & White Health), Evan H. Whitehead(Massachusetts General Hospital), Sandeep Nathan(University of Chicago), Vanessa Blumer(Massachusetts General Hospital), Ju Kim(Houston Methodist), Gavin Hickey(University of Pittsburgh Medical Center), Neil Harwani(Tufts Medical Center), Yijing Zhang(Donghua University), Borui Li(Tufts Medical Center), Shelley Hall
Cited by 88
Related Papers
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
|Nature|2022|858
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599
Criteria for Defining Stages of Cardiogenic Shock Severity
|Journal of the American College of Cardiology|2022|283